• Jorge Castelao Naval, José Luis Izquierdo Alonso, José Gallardo Carrasco, Ignacio Sánchez Hernández, Carlos Almonacid Sánchez, Jesús Fernández Francés, Pilar Resano Barrio, and Olga Mediano San Andrés.
• Sección de Neumología, Hospital Universitario de Guadalajara, Guadalajara, España. castelao@castelao.es
• Arch. Bronconeumol. 2013 Feb 1; 49 (2): 41-6.

ObjectivesTo analyze the clinical utility and economic impact of conventional transbronchial needle aspiration (TBNA) in patients with diagnosis of bronchogenic carcinoma (BC) and mediastinal lymphadenopathies in thoracic computed tomography (CT). To assess the predictive factors of valid aspirations.Patients And MethodsRetrospective observational study between 2006 and 2011 of all TBNA performed in patients with final diagnosis of BC and accessible hilar or mediastinal lymphadenopathies on thoracic CT.ResultsWe performed TBNA on 267 lymphadenopathies of 192 patients. In 34.9% of patients, two or more lymph nodes were biopsied. Valid aspirations were obtained in 153 patients (79.7%) that were diagnostic in 124 (64.6%). Multivariate analysis showed that factors associated with valid or diagnostic results are the diameter of the lymph node and the number of lymph nodes explored. TBNA was the only endoscopic technique that provided the diagnosis of BC in 54 patients (28.1%). Staging mediastinoscopy was avoided in 67.6% of patients. The prevalence of mediastinal lymph node involvement was 74.4%, sensitivity of TBNA was 86.2% and negative predictive value was 63.6%. Including mediastinoscopy and other avoided diagnostic techniques, TBNA saved 451.57 € per patient.ConclusionsTBNA is a clinically useful, cost-effective technique in patients with BC and mediastinal or hilar lymphadenopathies. It should therefore be performed on a regular basis during diagnostic bronchoscopy of these patients.Copyright © 2012 SEPAR. Published by Elsevier Espana. All rights reserved.

45 keywords...

hide…